medigraphic.com
ISSN 1405-1710 (Print)

2019, Number 2

<< Back Next >>

Rev Cent Dermatol Pascua 2019; 28 (2)

Redness and purulent discharge from the penis

Cruz‑Palacios C, Douriet‑Marín FA, Ramos‑Alamillo U, Romero‑Guzmán AK

Language: Spanish
References: 18
Page: 93-95
PDF size: 196.23 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Torres V, Camacho FM, Mihm M, Sober A, Sánchez-Carpintero I. Dermatología práctica Ibero-latinoamericana. 2a ed. México: Encuentros Científico Académicos; 2012. pp. 31.8-31.10.

  2. Carrada-Bravo T. Gonorrea diseminada: Caso clínico y revisión del tema. Rev Fac Med UNAM. 2007; 50: 14-16.

  3. Arenas R. Dermatología. Atlas, diagnóstico y tratamiento. 4a edición. México, D.F.: McGrawHill; 2009. pp. 277-279.

  4. Mayor MT, Roett MA, Uduhiri KA. Diagnosis and management of gonococcal infections. Am Fam Physician. 2012; 86: 931-938.

  5. Thompson LM. Tratamiento de la gonorrea en adolescentes y adultos. Rev Chil Infect. 2000; 17: 158-160.

  6. Suzaki A, Hayashi K, Kosuge K, Soma M, Hayakawa S. Disseminated gonococcal infection in Japan: a case report and literature review. Intern Med. 2011; 50: 2039-2043.

  7. Cruz PC, Ramos AU, González RA. Guía de prevención, diagnóstico y tratamiento de las ITS. México, D.F.: Fundación Mexicana para la Salud A.C.; 2011. pp. 27-28.

  8. Rice PA. Gonococcal arthritis (disseminated gonococcal infection). Infect Dis Clin North Am. 2005; 19: 853-861.

  9. Wentworth Ph, Judson FN, Gilchrisht MJR. Laboratory methods for diagnosis for sexually transmitted disease. 2nd edition. American Public Health Association; 1991. pp. 13-20.

  10. Bornstein M, Ahmed F, Barrow R, Risley JF, Simmons S, Workowski KA. Factors associated with primary care physician knowledge of the recommended regimen for treating gonorrhea. Sex Transm Dis. 2017; 44: 13-16.

  11. Kirkcaldy RD, Weinstock HS, Moore PC, Philip SS, Wiesenfeld HC, Papp JR et al. The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea. Clin Infect Dis. 2014; 59: 1083-1091.

  12. Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep. 2010; 59: 1-110.

  13. Centers for Disease Control and Prevention (CDC). Update to CDC’s Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep. 2012; 61: 590-594.

  14. Ison CA, Deal C, Unemo M. Current and future treatment options for gonorrhoea. Sex Transm Infect. 2013; 89 Suppl 4: iv52-iv56.

  15. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep. 2015; 64:60-68.

  16. Ross JDC, Brittain C, Cole M, Dewsnap C, Harding J, Hepburn T et al. Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial. Lancet. 2019; 393: 2511-2520.

  17. Taylor SN, Marrazzo J, Batteiger BE, Hook EW 3rd, Seña AC, Long J et al. Single-dose zoliflodacin (ETX0914) for treatment of urogenital gonorrhea. N Engl J Med. 2018; 379: 1835-1845.

  18. Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015; 64: 1-137




2020     |     www.medigraphic.com